CD4 News and Research

RSS

Benefits of breast-feeding might outweigh risk of vertical HIV transmission in developing countries

A series of studies presented Monday at the 14th Annual Conference on Retroviruses and Opportunistic Infections in Los Angeles suggest that the benefits of breast-feeding in developing countries might outweigh the risk of vertical HIV transmission, the San Francisco Chronicle reports.

28 Feb 2007

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein.

20 Feb 2007

Scientists discover vulnerable area on HIV that could lead to development of HIV/AIDS vaccine

Scientists on Wednesday announced they had identified a vulnerable area on HIV that might be susceptible to antibodies and could prevent the virus from infecting human cells, Reuters Health reports. The findings are published in the Feb. 15 issue of the journal Nature.

19 Feb 2007

Primary targets of HIV-1 infection in human vagina identified

The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.

15 Feb 2007

Interruptions in antiretroviral treatment increases risk of developing AIDS-related diseases

Interruptions in an HIV-positive person's antiretroviral treatment regimen can increase the risk of developing AIDS-related diseases and sometimes can be fatal, according to a study published Thursday in the New England Journal of Medicine, the Los Angeles Times reports.

2 Dec 2006

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

The results of a Phase I clinical trial of an experimental gene therapy aimed at treating HIV indicate that the therapy is safe and effective and also might sustain viral loads, according to a study published on Monday in the online edition of the Proceedings of the National Academy of Sciences, the AP/Washington Post reports.

8 Nov 2006

Weakened immune response resulting from HIV infection can lead to trouble when it comes to treating malaria

"Our study demonstrates that HIV-1 infected patients with suppressed immunity represent, next to children and pregnant women, an additional vulnerable group for malaria," says Jean-Pierre Van geertruyden, MD, MSc, lead author of the article.

7 Sep 2006

Kaiser highlights recently published Journal of Infectious Diseases studies

Summaries of studies recently published in the Journal of Infectious Diseases.

4 Sep 2006

HIV/AIDS fosters collaboration between traditional healers, western medicine in Zambia

The spread of HIV in Zambia is fostering collaboration between traditional healers and practitioners of Western medicine, IRIN News reports.

30 Aug 2006

'Switch' may turn off immune cells that fight HIV

An international research team believe they have discovered why the immune system is unable to control HIV infection.

20 Aug 2006

Natural HIV immunity

An international, multi-institutional research consortium is seeking to discover how a few HIV-infected individuals are naturally able to suppress replication of the virus.

16 Aug 2006

AIDS vaccine still long way off

Researchers are optimistic about a potential HIV/AIDS vaccine, even though none of the vaccines in development is likely to completely protect people from HIV transmission, participants at the XVI International AIDS Conference in Toronto said at a news conference Tuesday, Reuters reports.

16 Aug 2006

Serious gaps in Indian public knowledge about HIV

As India gears up implementation of national plans to fight HIV, infectious diseases experts at Johns Hopkins and elsewhere are pointing out serious gaps in public knowledge about the disease and identifying early problems in private clinics, where 70 percent of HIV-infected Indians receive their everyday medical care.

15 Aug 2006

Enrichment of regulatory CD4+CD25+ T cells by inhibition of phospholipase D signaling

A signaling molecule with an affinity for alcohol has yielded a rapid, inexpensive way to make large numbers of immune cells that work like beat cops keeping misguided cells from attacking the body.

8 Aug 2006

AIDS drugs still work but TB a deadly addition to the virus

According to a new report, ten years after they were introduced in Europe and North America, HIV/AIDS drugs remain effective but many patients are not being put on them soon enough.

7 Aug 2006

HIV virus can survive efforts to destroy it by hiding in the mucosal tissues of the intestine

UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine.

6 Aug 2006

Darunavir - first molecule to treat drug-resistant HIV

Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.

2 Aug 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Epstein-Barr virus may trigger multiple sclerosis

Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus.

3 May 2006